A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

The test relies on a magnetic nanoparticle linked to fluorescent molecules to detect pancreatic cancer proteins.

An AI tool appeared superior to two FDA-approved biomarkers for predicting how people with cancer will respond to immune ...

In January 2025, Aptose announced the initiation of the TUSCANY trial and dosing in the first cohort of newly-diagnosed AML patients with the lowest starting dose (40 mg) of TUS as part of the ...

The 18-gene MyProstateScore 2.0 (MPS2) test using first-catch non-digital rectal examination (DRE) urine is highly sensitive ...

Planned Systems International conducts tests and manages projects related to the rollout of the new Oracle Cerner electronic ...

For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...

A breakthrough in the fight against Alzheimer's was made by researchers at the University of Pittsburgh, where a test was ...

Prehospital measurement of glial fibrillary acidic protein (GFAP) can rapidly differentiate intracerebral hemorrhage (ICH) from ischemic stroke (IS) and stroke mimics.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...